Polymorph Analysis of ALZ-801 (Valiltramiprosate), a Valine-Conjugated Oral Prodrug of Tramiprosate in Late-Stage Clinical Development for Alzheimer’s Disease

Related articles

1. First-in-Class SAM-Competitive G9a Inhibitor FLAV-27 as a Disease-Modifying Therapy for Alzheimer’s Disease

   This article has 38 authors:

   1. Christian Griñán-Ferré
   2. Aina Bellver-Sanchis
   3. David Valle-Garcia
   4. Carla Barbaraci
   5. Fernando Romero-Beccera
   6. rohit Singh
   7. Foteini Vasilopoulou
   8. Alba Irisarri
   9. Carmen Martinez-Fernandez
   10. Juan Fafián-Labora
   11. María Arufe
   12. Carolin Wüst
   13. Aida Castellanos
   14. David Soto
   15. Núria Casals
   16. Rut Fadó
   17. Jennifer Pocock
   18. Gemma Navarro
   19. Cristina Val
   20. Bhanwar Singh Choudhary
   21. Jose Brea
   22. Maria Isabel Loza
   23. Alberto Lleo
   24. Juan Fortea
   25. Daniel Alcolea
   26. Anna Perez-Bosque
   27. LLuisa Miro
   28. Belén Pérez
   29. Sajid Rashid
   30. Zaoui Ali
   31. Manahil saqib
   32. Marcel.lí Carbó
   33. Ana Guerrero
   34. Santiago Vázquez
   35. Shaodong Dai
   36. Carmen Escolano
   37. Rafael Franco
   38. Mercè Pallàs

2. Isomerized Aβ in the brain can distinguish the status of amyloidosis in the Alzheimer’s Disease spectrum

   This article has 7 authors:

   1. Soumya Mukherjee
   2. Reid Coyle
   3. Celine Dubois
   4. Keyla Perez
   5. Catriona McLean
   6. Colin L. Masters
   7. Blaine R. Roberts

3. Acetylcholinesterase Inhibitory Potential of Plant-Based Phenolics in the Treatment of Alzheimer's Disease: An In Silico Approach

   This article has 11 authors:

   1. Mojeed Ayoola Ashiru
   2. Rasheed Adewale Adigun
   3. Musa Oladayo Babalola
   4. Sherif Olabisi Ogunyemi
   5. Idris Oladimeji Junaid
   6. Maryam Titilayo Bello-Hassan
   7. Mojisola Adebimpe Fategbe
   8. Myah Grace Baker
   9. Kazeem Adelani Alabi
   10. Prince Ozioma Emmanuel
   11. Mohammed O. Balogun